Small Lymphocytic Lymphoma
Showing NaN - NaN of 16
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
-
Birmingham, Alabama
- +484 more
Aug 24, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)
Recruiting
- Lymphoma, Non-Hodgkin
- +9 more
- NKX019
-
Denver, Colorado
- +6 more
Jan 19, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- +3 more
-
Birmingham, Alabama
- +159 more
Feb 20, 2020
Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)
Completed
- Follicular Lymphoma
- +3 more
-
Fullerton, California
- +40 more
Jun 14, 2019
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Duarte, California
- +107 more
Nov 27, 2017
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Duvelisib, Venetoclax)
Withdrawn
- Chronic Lymphocytic Leukemia
- +2 more
-
Tucson, Arizona
- +9 more
Jul 22, 2016
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Chicago, Rochester, Columbus (Motexafin Gadolinium)
Terminated
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Motexafin Gadolinium
-
Chicago, Illinois
- +2 more
May 7, 2014
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Leukemia Trial in United States (motexafin gadolinium)
Completed
- Chronic Lymphocytic Leukemia
- +3 more
- motexafin gadolinium
-
Los Angeles, California
- +3 more
Sep 10, 2008